Acupuncture for Classical Trigeminal Neuralgia: Meta-Analysis Points to Adjuvant Benefit Added to Carbamazepine, with Important Limitations

Classical trigeminal neuralgia is characterized by paroxysmal, brief, and extremely intense attacks of pain in the territory of the trigeminal nerve, frequently triggered by light sensory stimuli (trigger zones). It is one of the most disabling forms of pain in neurological practice. The first-line pharmacologic treatment is carbamazepine, with oxcarbazepine and baclofen as alternatives; in refractory cases, invasive procedures are used (Gasser ganglion block, microvascular decompression, stereotactic radiosurgery). Acupuncture has been investigated as an adjuvant to reduce medication dose and improve symptomatic response.

What the Literature Shows

Meta-analyses suggest a moderate benefit of adjuvant acupuncture compared with carbamazepine alone, with reduction in intensity and frequency of attacks and potential impact on medication dose. The findings, however, come from predominantly Asian trials with methodologic limitations (active control, difficult blinding, small samples). In refractory trigeminal neuralgia — with multiple pharmacologic therapy failure — acupuncture does not replace the interventional options (microvascular decompression, radiosurgery) but may integrate palliative management.

Important Limitations

The literature has several relevant limitations: most trials are of Asian origin with risk of publication bias; diagnostic criteria for trigeminal neuralgia do not always follow strict ICHD-3; blinding is particularly difficult; and there are few trials with follow-up > 3 months. Neuroimaging investigation (brain MRI to rule out vascular conflict or structural lesion) is mandatory before any continued therapy — acupuncture cannot delay this investigation.